US Business
FDA Probes Cause of Failed Johnson & Johnson Covid-19 Vaccine Batch
The scrutiny follows the drugmaker’s disclosure that it scrapped distribution of doses after an ingredient didn’t meet quality standards at a contract manufacturing facility.
